BENSALEM, Pa.-- (BUSINESS WIRE) -- Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of IMS Health, Inc. (“IMS” or the “Company”) (NYSE:RX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to TPG Capital (“TPG”) and the CPP Investment Board (“CPPIB”).

The investigation concerns the price to be paid by TPG and CPPIB to IMS shareholders and the process by which IMS’ Board of Directors is addressing the transaction. Under the agreement, IMS shareholders will receive $22.00 cash for each share of IMS common stock they own.

If you own shares of IMS, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or visit www.howardsmithlaw.com. You may also email my firm at howardsmith@howardsmithlaw.com.